699 related articles for article (PubMed ID: 16913090)
21. Treatment options for Graves' orbitopathy.
Marcocci C; Altea MA; Leo M
Expert Opin Pharmacother; 2012 Apr; 13(6):795-806. PubMed ID: 22404364
[TBL] [Abstract][Full Text] [Related]
22. [Graves' ophthalmopathy from the internist's perspective].
Laubner K; Weber WA; Seufert J
Ophthalmologe; 2011 May; 108(5):410-6. PubMed ID: 21590351
[TBL] [Abstract][Full Text] [Related]
23. Thyroid-associated orbitopathy: who and how to treat.
Dickinson J; Perros P
Endocrinol Metab Clin North Am; 2009 Jun; 38(2):373-88, ix. PubMed ID: 19328417
[TBL] [Abstract][Full Text] [Related]
24. An update on medical management of Graves' ophthalmopathy.
Bartalena L; Marcocci C; Tanda ML; Piantanida E; Lai A; Marinò M; Pinchera A
J Endocrinol Invest; 2005 May; 28(5):469-78. PubMed ID: 16075933
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology of Graves' orbitopathy.
Putta-Manohar S; Perros P
Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():182-5. PubMed ID: 20467360
[TBL] [Abstract][Full Text] [Related]
26. The role of genetics in Graves' disease and thyroid orbitopathy.
Kim N; Hatton MP
Semin Ophthalmol; 2008; 23(1):67-72. PubMed ID: 18214794
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of Graves' ophthalmopathy with oral or intravenous corticosteroids].
Brauer VF; Scholz GH
Med Klin (Munich); 2004 Feb; 99(2):71-6. PubMed ID: 14963657
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology of Graves' orbitopathy (GO) and relationship with thyroid disease.
Lazarus JH
Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):273-9. PubMed ID: 22632364
[TBL] [Abstract][Full Text] [Related]
29. Prevention of graves' orbitopathy: early diagnosis of thyroid-associated orbitopathy in Graves' disease.
Mourits MP
Orbit; 2008; 27(6):399-400. PubMed ID: 19085291
[No Abstract] [Full Text] [Related]
30. Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center.
Tanda ML; Piantanida E; Liparulo L; Veronesi G; Lai A; Sassi L; Pariani N; Gallo D; Azzolini C; Ferrario M; Bartalena L
J Clin Endocrinol Metab; 2013 Apr; 98(4):1443-9. PubMed ID: 23408569
[TBL] [Abstract][Full Text] [Related]
31. Decreased nerve growth factor levels in hyperthyroid Graves' ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases.
Molnár I; Bokk A
Cytokine; 2006 Aug; 35(3-4):109-14. PubMed ID: 17008110
[TBL] [Abstract][Full Text] [Related]
32. [Diagnosis and treatment of dysthyroid orbitopathy: a multidisciplinary disease].
Leray B; Imbert P; Thouvenin D; Boutault F; Caron P
J Fr Ophtalmol; 2013 Dec; 36(10):874-85. PubMed ID: 24239215
[TBL] [Abstract][Full Text] [Related]
33. Type 2 diabetic patients with Graves' disease have more frequent and severe Graves' orbitopathy.
Le Moli R; Muscia V; Tumminia A; Frittitta L; Buscema M; Palermo F; Sciacca L; Squatrito S; Vigneri R
Nutr Metab Cardiovasc Dis; 2015 May; 25(5):452-7. PubMed ID: 25746910
[TBL] [Abstract][Full Text] [Related]
34. Occurrence of Graves' hyperthyroidism and Graves' orbitopathy after fine-needle aspiration biopsy of thyroid nodules.
Lanzolla G; Marcocci C; Marinò M
J Endocrinol Invest; 2020 Jul; 43(7):1033-1034. PubMed ID: 32077044
[No Abstract] [Full Text] [Related]
35. Knowledge of Thyroid Eye Disease in Graves' Disease Patients With and Without Orbitopathy.
Edmunds MR; Boelaert K
Thyroid; 2019 Apr; 29(4):557-562. PubMed ID: 30688164
[TBL] [Abstract][Full Text] [Related]
36. Long-term results of surgical treatment in Graves' disease orbitopathy. Is there a correlation between the extent of thyroidectomy and the course of orbithopathy?
Maurer E; Dănilă R; Dominguez E; Osei-Agymang T; Zielke A; Hassan I
Chirurgia (Bucur); 2008; 103(3):291-5. PubMed ID: 18717277
[TBL] [Abstract][Full Text] [Related]
37. Radioactive iodine treatment for Graves' hyperthyroidism: incidence of Graves orbitopathy.
Quah NQX; Sobti MM; Wren AM; Scawn R; Kalogianni E; Cleland J; Maenhout A
Nucl Med Commun; 2024 Feb; 45(2):103-107. PubMed ID: 37982569
[TBL] [Abstract][Full Text] [Related]
38. Clinical update: treatment of hyperthyroidism in Graves' ophthalmopathy.
Azzam I; Tordjman K
Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():193-7. PubMed ID: 20467362
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and natural history of Graves' orbitopathy in the XXI century.
Piantanida E; Tanda ML; Lai A; Sassi L; Bartalena L
J Endocrinol Invest; 2013 Jun; 36(6):444-9. PubMed ID: 23587873
[TBL] [Abstract][Full Text] [Related]
40. Safety of non-standard regimen of systemic steroid therapy in patients with Graves' orbitopathy: a single-centre experience.
Sawicka-Gutaj N; Gruszczyński D; Zawalna N; Nijakowski K; Skiba A; Pochylski M; Sowiński J; Ruchała M
Pharmacol Rep; 2024 Feb; 76(1):185-194. PubMed ID: 38273183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
